ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway
We highlighted the promoting role of ADAMTS4 in lung cancer progression and proposed ADAMTS4 as a promising therapeutic target for lung cancer patients.
Authors
- Yudong Zhou (ORCID: https://orcid.org/0000-0002-6364-3869)
- Xingxiang Pu (ORCID: https://orcid.org/0000-0002-2743-7080)
- Wensheng Yang (ORCID: https://orcid.org/0000-0002-7265-6565)
- Kang‐Hsi Wu (ORCID: https://orcid.org/0000-0001-9145-0522)
- Kelin She
- Shiya Luo
- Yi Wen Kong (ORCID: https://orcid.org/0000-0002-4223-971X)
- Lin Wu (ORCID: https://orcid.org/0000-0003-4348-372X)
- Xuelian Xiao
- Wei Zhai
- Jing Ge
Institutions
- Central South University (CN)
- Shaoyang University (CN)
- Hunan Cancer Hospital (CN)
- Hunan Provincial People's Hospital (CN)
- Sansure Biotech (China) (CN)
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
- University of South China (CN)
Publication Details
- Journal
- Biology Direct
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1186/s13062-024-00512-y
- Citations
- 2
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Beijing Xisike Clinical Oncology Research Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- University of Texas MD Anderson Cancer Center